Article
Extracellular Vesicle (EV) Targeted Cells Release Secondary Effector EVs: Indication of How We Can Account for Histocompatibility and Disease Specificity of MSC EV Treatments
2025-05-12
Abstract excerpt
The central hypothesis presented here is that released extracellular vesicles (EVs) can act primarily on targeted cells to induce the production of secondary EVs to mediate the final biological events. Compared here are different instances. In one, EVs, primarily produced by CD8+ suppressor T cells, are activated in immune tolerance. These EVs transfer to companion recipient macrophages (Macs) the ability to gener...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d611a0c-76f0-5726-942d-26beb483c756
- DOI
- 10.20944/preprints202505.0896.v1
